Center for Biologics Evaluation and Research
The Center for Biologics Evaluation and Research is one of six main centers for the U.S. Food and Drug Administration, which is a part of the U.S. Department of Health and Human Services. The current Director of CBER is Peter Marks, M.D., PhD. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Center for Biologics Evaluation and Research, United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
62%
Total
Publications
5K
Total Open
Publications
3.1K
Total
Citations
241K
Open Access
Percentage
62%
Total
Publications
5K
Total Open
Publications
3.1K
Total
Citations
241K
Breakdown
Publisher Open
15%
Both
31%
Other Platform Open
16%
Closed
38%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 39%
899
Hybrid 28%
640
No Guarantees 33%
771
Other Platform Open
Domain 92%
2.2K
Public 12%
272
Institution 11%
260
Other Internet 7%
158
Preprint 6%
134
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 2.2K |
Europe PMC | Domain | 1.4K |
Semantic Scholar | Public | 249 |
DOI | Other Internet | 97 |
bioRxiv | Preprint | 86 |
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI | Institution | 52 |
Figshare | Public | 39 |
CiteSeer X | Other Internet | 26 |
medRxiv | Preprint | 24 |
DANS - Data Archiving and Networked Services - NARCIS - National Academic Research and Collaborations Information System | Institution | 19 |